Bluejay Diagnostics, Inc.
BJDX- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001704287
In the last 90 days, Bluejay Diagnostics, Inc. insiders filed 1 open-market purchase and 1 sale; 8 institutions reported holding it in 13F filings for Q2 2026, worth $259.3K in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Bluejay Diagnostics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 11
- +1 vs. Q1 2023
- Shares held
- 178.7K
- +42.0K (+30.7%) vs. Q1 2023
- Total value
- $47.4K
- −$8.34K (−15.0%) vs. Q1 2023
- New holders
- 4
- 2 more added
- Sold out
- 3
- 1 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BJDX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 8 | $259.3K |
| Q1 2026 | 6 | $108.2K |
| Q4 2025 | 9 | $112.3K |
| Q3 2025 | 4 | $142.7K |
| Q2 2025 | 5 | $170.3K |
| Q1 2025 | 4 | $9.61K |
| Q4 2024 | 3 | $12.2K |
| Q3 2024 | 13 | $129.0K |
| Q2 2024 | 5 | $118.6K |
| Q1 2024 | 9 | $344.7K |
| Q4 2023 | 7 | $243.4K |
| Q3 2023 | 6 | $99.8K |
| Q2 2023 | 11 | $47.4K |
| Q1 2023 | 10 | $55.7K |
| Q4 2022 | 14 | $109.0K |
| Q3 2022 | 12 | $146.0K |
| Q2 2022 | 12 | $258.0K |
| Q1 2022 | 8 | $98.0K |
| Q4 2021 | 9 | $267.0K |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Bluejay Diagnostics, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 49,100 | $13.0K | 0.00% | +12,600+34.5% | Added |
| HRT Financial LP | 29,907 | $8.00K | 0.00% | +29,907 | New |
| Geode Capital Management, LLC | 29,139 | $7.86K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 27,094 | $7.12K | 0.00% | +27,094 | New |
| Vanguard Group Inc | 15,899 | $4.18K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 11,699 | $3.08K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 10,132 | $2.67K | 0.00% | −70−0.7% | Reduced |
| UBS Group AG | 5,158 | $1.36K | 0.00% | +5,158 | New |
| Advisor Group Holdings, Inc. | 500 | $131 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 74 | $19 | 0.00% | +4+5.7% | Added |
| Coppell Advisory Solutions LLC | 12 | – | – | +12 | New |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −12,254−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −10,462−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −10,031−100.0% | Sold out |